Adjuvants are added to vaccines to improve protection, extend the duration of protection and reduce the dose or number of boosters required.
Tag: Adjuvant
Diversifying the next generation of TB vaccines
NIH’s National Institute of Allergy and Infectious Diseases awarded Texas Biomedical Research Institute and The Access to Advanced Health Institute in Seattle, Washington, a $3.5 million, five-year Innovation for Tuberculosis Vaccine Discovery grant.